NCD Japan Forum 2011
date : 11/29/2011
On the 29th September 2011, the Health and Global Policy Institute hosted the “NCD Forum 2011 ~ Chronic Disease Control and the NCD Agenda in Developed Countries” at the Ambassador’s Residence of the British Embassy in Tokyo.
In September, the importance of tackling non-communicable diseases (NCDs; or chronic diseases) was highlighted to the world as it became the main topic of discussion at the U.N. High Level Meeting. This forum was therefore held with a view to reminding the participants of this important issue, whilst also providing a platform for the discussion of future NCD control strategies within Japan, the sharing of perspectives and ambitions of various stakeholders in this field, and the exchange of views on the future measures to be taken by Japan.
Japan has a record of making significant contributions to infectious disease control in its role as a major donor to the U.N. In light of its knowledge in dealing with chronic disease, it is also expected that it will exert international initiative in the area of NCDs.
The Forum was opened with greetings from H.M. Ambassador David Warren and a keynote speech from Dr. Keizo Takemi, Professor at the School of Political Science and Economics at Tokai University and Senior Fellow at the Japan Center for International Exchange. This was then followed by presentations from Ms. Judith Watt, Strategic Consultant to the NCD Alliance (an international collaborative organization dealing with NCD issues), and Dr. Hajime Inoue, Director of the Department of Health and Welfare in Chiba Prefecture. Under the title “What are NCDs? – Implications for Japan and its Global Role”, Ms. Watt and Dr. Inoue served to both provide an introduction to, and also to deepen the audiences’ understanding of the current situation with NCDs.
In the latter half of the Forum, a panel discussion took place with a further four experts (Dr. Ryozo Nagai, Department of Cardiovascular Medicine, The University of Tokyo; Dr. Masato Mugitani, Assistant Minister for Global Health, Ministry of Health and Welfare; Mr. David Brennan, President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA); Ms. Loyce Pace, Director of Health Policy, Lance Armstrong Foundation), under the theme of “The Roles that should be Played by Different Sectors – Global Partnerships for NCD and Beyond”. In their positions as representatives of the different stakeholders in the NCD issue, each panelist shared their thoughts on the future contributions that can be made and the initiatives that should be undertaken from their varying perspectives. The panelists also further engaged in lively discussion and an exchange of views as to how the knowledge Japan has accumulated thus far in health policy can benefit the rest of the world in the NCD field, and the contributions it could make.
Exhibition date:2011-11-29
Top Research & Recommendations Posts
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)









